NCT03677596 2023-11-22
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
Pfizer
Phase 4 Completed
Clinical Trials
8 trialsNCT03991884 2023-07-06
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
University of Washington
Phase 1 Completed
NCT00849147 2023-01-04
Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)
Medical College of Wisconsin
Phase 2 Completed
NCT00864227 2022-12-14
Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)
Medical College of Wisconsin
Phase 2 Completed
NCT01786135 2017-10-19
A Safety Study of SGN-CD19A for B-Cell Lymphoma
Seagen Inc.
Phase 1 Completed
NCT01116193 2017-09-14
RV-405 LAL
Institut de Cancérologie de la Loire
Phase 2 Completed
NCT01786096 2017-07-02
A Safety Study of SGN-CD19A for Leukemia and Lymphoma
Seagen Inc.
Phase 1 Completed
NCT00822432 2012-07-31
COMETH
Assistance Publique - Hôpitaux de Paris
Completed